Sunday, 5 June 2022

Cancer research: Amgen drug extends survival in some inoperable colon cancers

Cancer research: Amgen drug extends survival in some inoperable colon cancers

The following are summaries of some of the cancer research advances being presented the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

New data sets stage for broader use of AstraZeneca breast cancer drug

AstraZeneca and Daiichi Sankyo's Enhertu extended survival by more than six months in patients with a form of advanced breast cancer compared to standard chemotherapy, according to data presented on Sunday.

Beijing to allow indoor dining, further easing COVID curbs

Beijing will further relax COVID-19 curbs by allowing indoor dining, as China's capital steadily returns to normal with inflections falling, state media said on Sunday.

North Korea reports some 73,780 people with fever amid COVID wave, KCNA says

North Korea reported some 73,780 more people with fever symptoms amid its first-ever coronavirus outbreak, North Korean state media KCNA said on Sunday.

Baby formula shortage could ease as Abbott reopens Michigan plant

Abbott Laboratories said on Saturday that it has reopened its baby formula production plant in Sturgis, Michigan, taking a step toward alleviating an acute nationwide shortage that has sent parents scrambling for supplies.

H&H working with FDA to up U.S. baby formula supplies

Health and Happiness (H&H) International Holdings Ltd is working closely with the U.S. Food and Drug Administration (FDA) to gain approval to send more infant formula supplies to the United States, a top executive said.

North Korea reports 79,100 more people with fever, one new death amid COVID wave

North Korea reported some 79,100 more people with fever symptoms and one additional death amid its first-confirmed coronavirus outbreak, state media KCNA said on Saturday.

Cancer research: Liquid biopsy identifies who can skip chemo after colon cancer surgery

The following are summaries of some of the cancer research advances being presented the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Gilead drug modestly delays breast cancer progression in late-stage trial

Gilead Sciences Inc's Trodelvy extended by 1.5 months, or 34%, the length of time women with advanced stages of a common type of breast cancer lived without their disease worsening, according to trial data presented on Saturday.

India approves Biological E. COVID shot as a booster

India has approved Hyderabad-based drugmaker Biological E's COVID-19 vaccine as the first mix-and-match booster dose in the country, the company said on Saturday.

Related Videos

Monkeypox "will not be like COVID" - Spanish microbiologist

Monkeypox can be contained if we act now: WHO

N.Korea reports more deaths amid COVID lockdown